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Overview of Psychotic Disorders
(American Psychiatric Association [APA], 2013; Fazel & Danesh, 2002)
Schizophrenia, Schizoaffective 
Characterized by Hallucinations & 
Delusions
1% of U.S. population
Clinicians need accurate information for:
Assessment
Understanding patient experience
Treatment
Two-Part Cross-Sectional Study
Overall Cognitive Symptom Trajectory
Impact of Comorbid Mood Disorders
Processing 
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(Dickinson, & Harvey, 2009; Garcia, Viechtbauer, Simons, van Os, & Krabbendam, 2009; Keefe, & Harvey, 2012)
Research Question 1
What is the trajectory of cognitive symptoms for 
patients as they age?
Research Question 2
How would comorbid mood disorders impact 
cognitive symptom severity?
Research So Far
(American Psychiatric Association [APA], 2013; Fazel & Danesh, 2002)
Follow Patients over Time
Compare across Age Groups
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Neurodegenerative Trajectory Model
(Irani et al., 2011; Herold, Schmid, Lässer, Seidl, & Schröder, 2017)
Research Question 1
What is the trajectory of cognitive symptoms for 
patients as they age?
Research Question 1
Hypotheses: Neurodegenerative Trajectory
Mood Disorders
Anxiety
Depression
Mania
Research Question 2
Exploratory Analyses: 
Due to the limited and mixed research, we could 
not form formal hypotheses
(Bora, Yucel, & Pantelis, 2009; Depp et al., 2007)
How would comorbid mood disorders impact 
cognitive symptom severity?
Method
73.7%
Male
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50.1%
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Other
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Offender
Prison Transfer
Other
Years at Hospital 
M(SD) = 2.46(4.30)
48.7%
19.1%
25.3%
3.1%
3.2% 0.6%
Measures
Minnesota Multiphasic Personality Inventory –2 
Restructured Form (MMPI-2-RF)
VRIN-r COG
Variable Response Inconsistency – Revised
(VRIN-r)
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Cognitive 
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VRIN-r
(Ben-Porath, 2012; Ben-Porath & Tellegen, 2008/2011)
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(Burchett & Ben-Porath, 2010; Ben-Porath, 2012)
Young 
(18-34 years)
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Procedures: RQ 1
Removed Invalid Protocols for COG analyses
Procedures for Research Question 1
Analysis of Variance (ANOVA) to compare mean 
scores across 3 groups
Group 1 Group 2 Group 3
Procedures: RQ 2
Sz Only Sz + Mood 
Young Young
Middle Middle
Older Older
Schizophrenia (Sz)
Procedures for Research Question 2
Independent Samples t-tests to compare mean 
scores across 2 groups
Group 1 Group 2
Sz Only Sz Mood 
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Procedures for Research Question 2
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Procedures for Research Question 2
Results
Research Question 1
What is the trajectory of cognitive symptoms for 
patients as they age?
Research Question 1
Hypotheses: Neurodegenerative Trajectory
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No significant differences were found 
F(2, 705) = 1.52, p = .22
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F(2, 456) = .69, p = .51
Research Question 1
Hypotheses: Neurodegenerative Trajectory
Research Question 1
Results: Neither Trajectory
Research Question 2
Exploratory Analyses: 
Due to the limited and mixed research, we could 
not form formal hypotheses
(Bora, Yucel, & Pantelis, 2009; Depp et al., 2007)
How would comorbid mood disorders impact 
cognitive symptom severity?
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Research Question 2
Results: 
Comorbid mood disorders did not significantly 
impact cognitive symptom severity.
Conclusions & Future Directions
Research Question 1
Patients may not experience increased cognitive 
symptom severity as they age 
Research Question 2
Having mood disorders may not impact cognitive 
dysfunction
Clinicians may not have to worry about 
cognitive symptoms worsening over time due to 
age
Comorbid mood disorders may not impact the 
level of treatment needed for cognitive 
symptoms
How does this inform Clinicians?
Future Directions in Research
Use more direct and specific measures of 
cognitive symptoms
Among larger samples and younger age 
groups
Controlling for additional variables 
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Questions?
Schizophrenia Only
Schizophrenia Disorders: 295.10, 295.30, 295.40, 295.50, 295.60, 295.90
Schizophrenia with Mood
Schizoaffective Disorder: 295.70, 295.770
Depressive/Anxiety Disorders: 296.22, 296.24, 296.30, 296.31, 296.32, 296.34, 296.35
Bipolar Disorders: 296.00, 296.40, 296.41, 296.42, 296.43, 296.44, 296.45, 296.46, 296.50, 
296.51, 296.52, 296.53, 296.54, 296.55, 296.60, 296.7, 296.70, 296.62, 296.64
Excluded from Analyses:
Drug-Induced Psychotic Disorders: 291.3, 291.50, 292.10, 292.11, 292.12
Psychotic Disorders due to Medical Condition: 293.81, 293.82
Mood Disorders due to Medical Condition: 293.83
Delusional Disorders, Brief Psychotic Disorder, Psychotic Disorder NOS: 297.10, 298.8, 
298.9
DSM-IV-TR Diagnostic Codes
